LLY pity that Nordisk is a direct Rival of Eli Lilly, both are my absolute favorite emerging Medical research companies, in a way, it's good for the consumer market, I am investing in both, think Nvidia AMD rivalry. At least for the time being, Eli Lilly is leading ahead.
LLY Tirzepatide should get approved to replace semaglutide in Canada obesity, that goes for several other markets including middle east UAE and Saudi Arabia Eli Lilly will be selling faster than it could produce.
LLY for long, and for investors, this is absolutely not a stock that you wanna pass on. I personally don't think that there is an accurate evaluation on it. Price of 1000 is only on charts, because this thing will take on mega companies like Pfizer and Astra Zeneca, and I would assume it will keep going up, way past any analyst rating for it, because it's a winning company. The only thing I regret is not having more funds to buy more shares, regardless of the price, all the way to it's previous ATH, but obviously the lower the better